Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives

Roberto Fogari, Annalisa Zoppi, Amedeo Mugellini, Paola Preti, Luca Corradi, Paola Lusardi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

To evaluate the effect of manidipine 10 mg on 24-hour ambulatory blood pressure (BP) and heart rate (HR) in very elderly hypertensive patients, 54 patients aged 76-89 years (mean age 81.8 years) with systolic blood pressure (SBP) > 160 mmHg and diastolic blood pressure (DBP) > 90 mmHg were studied. After a 4-week placebo washout period, patients were randomized to receive manidipine 10 mg or placebo, both administered once daily for 8 weeks. Patients were checked after the initial run-in placebo phase and every 4 weeks thereafter. At each visit casual BP and HR were measured. At the end of the placebo period and after 8 weeks of active treatment, noninvasive 24-hour ambulatory blood pressure measurement (ABPM) was performed. Manidipine significantly lowered casual sitting and standing SBP (P <0.001) and DBP (P <0.001) at the trough level. ABPM showed a significant decrease in 24-hour SBP and DBP values (P <0.001), daytime SBP and DBP (P <0.001), and night-time SBP (P <0.001) and DBP (P <0.005). In addition, ABPM confirmed a consistent antihypertensive activity throughout the 24-hour dosing interval, without effect on the circadian BP profile. The trough/peak ratio was 0.67 for SBP and 0.59 DBP. No statistically significant change in HR was observed. The treatment was well tolerated, and there were no serious side effects. In conclusion, in very elderly hypertensive patients, once-daily administration of manidipine 10 mg was well tolerated and effective in reducing casual as well ambulatory BP.

Original languageEnglish
Pages (from-to)243-248
Number of pages6
JournalCardiovascular Drugs and Therapy
Volume13
Issue number3
DOIs
Publication statusPublished - 1999

Fingerprint

manidipine
Blood Pressure

Keywords

  • Blood pressure monitoring
  • Elderly hypertensives
  • Manidipine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives. / Fogari, Roberto; Zoppi, Annalisa; Mugellini, Amedeo; Preti, Paola; Corradi, Luca; Lusardi, Paola.

In: Cardiovascular Drugs and Therapy, Vol. 13, No. 3, 1999, p. 243-248.

Research output: Contribution to journalArticle

Fogari, Roberto ; Zoppi, Annalisa ; Mugellini, Amedeo ; Preti, Paola ; Corradi, Luca ; Lusardi, Paola. / Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives. In: Cardiovascular Drugs and Therapy. 1999 ; Vol. 13, No. 3. pp. 243-248.
@article{0c73125dbe3b472a8522ba2526e8b9ec,
title = "Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives",
abstract = "To evaluate the effect of manidipine 10 mg on 24-hour ambulatory blood pressure (BP) and heart rate (HR) in very elderly hypertensive patients, 54 patients aged 76-89 years (mean age 81.8 years) with systolic blood pressure (SBP) > 160 mmHg and diastolic blood pressure (DBP) > 90 mmHg were studied. After a 4-week placebo washout period, patients were randomized to receive manidipine 10 mg or placebo, both administered once daily for 8 weeks. Patients were checked after the initial run-in placebo phase and every 4 weeks thereafter. At each visit casual BP and HR were measured. At the end of the placebo period and after 8 weeks of active treatment, noninvasive 24-hour ambulatory blood pressure measurement (ABPM) was performed. Manidipine significantly lowered casual sitting and standing SBP (P <0.001) and DBP (P <0.001) at the trough level. ABPM showed a significant decrease in 24-hour SBP and DBP values (P <0.001), daytime SBP and DBP (P <0.001), and night-time SBP (P <0.001) and DBP (P <0.005). In addition, ABPM confirmed a consistent antihypertensive activity throughout the 24-hour dosing interval, without effect on the circadian BP profile. The trough/peak ratio was 0.67 for SBP and 0.59 DBP. No statistically significant change in HR was observed. The treatment was well tolerated, and there were no serious side effects. In conclusion, in very elderly hypertensive patients, once-daily administration of manidipine 10 mg was well tolerated and effective in reducing casual as well ambulatory BP.",
keywords = "Blood pressure monitoring, Elderly hypertensives, Manidipine",
author = "Roberto Fogari and Annalisa Zoppi and Amedeo Mugellini and Paola Preti and Luca Corradi and Paola Lusardi",
year = "1999",
doi = "10.1023/A:1007700326811",
language = "English",
volume = "13",
pages = "243--248",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives

AU - Fogari, Roberto

AU - Zoppi, Annalisa

AU - Mugellini, Amedeo

AU - Preti, Paola

AU - Corradi, Luca

AU - Lusardi, Paola

PY - 1999

Y1 - 1999

N2 - To evaluate the effect of manidipine 10 mg on 24-hour ambulatory blood pressure (BP) and heart rate (HR) in very elderly hypertensive patients, 54 patients aged 76-89 years (mean age 81.8 years) with systolic blood pressure (SBP) > 160 mmHg and diastolic blood pressure (DBP) > 90 mmHg were studied. After a 4-week placebo washout period, patients were randomized to receive manidipine 10 mg or placebo, both administered once daily for 8 weeks. Patients were checked after the initial run-in placebo phase and every 4 weeks thereafter. At each visit casual BP and HR were measured. At the end of the placebo period and after 8 weeks of active treatment, noninvasive 24-hour ambulatory blood pressure measurement (ABPM) was performed. Manidipine significantly lowered casual sitting and standing SBP (P <0.001) and DBP (P <0.001) at the trough level. ABPM showed a significant decrease in 24-hour SBP and DBP values (P <0.001), daytime SBP and DBP (P <0.001), and night-time SBP (P <0.001) and DBP (P <0.005). In addition, ABPM confirmed a consistent antihypertensive activity throughout the 24-hour dosing interval, without effect on the circadian BP profile. The trough/peak ratio was 0.67 for SBP and 0.59 DBP. No statistically significant change in HR was observed. The treatment was well tolerated, and there were no serious side effects. In conclusion, in very elderly hypertensive patients, once-daily administration of manidipine 10 mg was well tolerated and effective in reducing casual as well ambulatory BP.

AB - To evaluate the effect of manidipine 10 mg on 24-hour ambulatory blood pressure (BP) and heart rate (HR) in very elderly hypertensive patients, 54 patients aged 76-89 years (mean age 81.8 years) with systolic blood pressure (SBP) > 160 mmHg and diastolic blood pressure (DBP) > 90 mmHg were studied. After a 4-week placebo washout period, patients were randomized to receive manidipine 10 mg or placebo, both administered once daily for 8 weeks. Patients were checked after the initial run-in placebo phase and every 4 weeks thereafter. At each visit casual BP and HR were measured. At the end of the placebo period and after 8 weeks of active treatment, noninvasive 24-hour ambulatory blood pressure measurement (ABPM) was performed. Manidipine significantly lowered casual sitting and standing SBP (P <0.001) and DBP (P <0.001) at the trough level. ABPM showed a significant decrease in 24-hour SBP and DBP values (P <0.001), daytime SBP and DBP (P <0.001), and night-time SBP (P <0.001) and DBP (P <0.005). In addition, ABPM confirmed a consistent antihypertensive activity throughout the 24-hour dosing interval, without effect on the circadian BP profile. The trough/peak ratio was 0.67 for SBP and 0.59 DBP. No statistically significant change in HR was observed. The treatment was well tolerated, and there were no serious side effects. In conclusion, in very elderly hypertensive patients, once-daily administration of manidipine 10 mg was well tolerated and effective in reducing casual as well ambulatory BP.

KW - Blood pressure monitoring

KW - Elderly hypertensives

KW - Manidipine

UR - http://www.scopus.com/inward/record.url?scp=0033031620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033031620&partnerID=8YFLogxK

U2 - 10.1023/A:1007700326811

DO - 10.1023/A:1007700326811

M3 - Article

VL - 13

SP - 243

EP - 248

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 3

ER -